Table 6.
Outcomes after LT for neuroendocrine liver metastases
Author | Patients, n | Criteria for LT | RR, % | RFS, % | OS rate, % |
---|---|---|---|---|---|
Korda et al. [62] | 10 | Not specified | Median 33 months 50 | 1/5 years 80/43 | 1/5 years 89/71 |
| |||||
Ruzzenente et al. [63] | 28 | Milan criteria | 5 years 83 | ||
| |||||
Vaivi et al. [61] | 206 | Not specified | Median 28 (1–192) months 34 | 1/3/5/10 years 89.1/75.3/64.9/46.1 |
LT, liver transplantation; RR, recurrence rate; RFS, recurrence-free survival; OS, overall survival.